Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Laboratory Proficiency Testing"" wg kryterium: Temat


Tytuł :
Interlaboratory Agreement of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serologic Assays in the Expedited College of American Pathologists Proficiency Testing Program.
Autorzy :
Tacker DH; The Department of Pathology, Anatomy, and Laboratory Medicine, West Virginia University, Morgantown (Tacker).
Bashleben C; Laboratory Improvement Programs, Surveys (Bashleben), College of American Pathologists, Northfield, Illinois.
Long TC; Department of Biostatistics (Long), College of American Pathologists, Northfield, Illinois.
Theel ES; The Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota (Theel).
Knight V; The Department of Pediatrics, Section of Allergy and Immunology, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora (Knight).
Kadkhoda K; Immunopathology Laboratory, Robert Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Kadkhoda).
Rhoads DD; The Department of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio (Rhoads).
Linden MA; The Department of Laboratory Medicine and Pathology, University of Minnesota Medical Center, Minneapolis (Linden).
Fink SL; The Department of Laboratory Medicine and Pathology, University of Washington, Seattle (Fink).
Pokaż więcej
Źródło :
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2021 May 01; Vol. 145 (5), pp. 536-542.
Typ publikacji :
Journal Article
MeSH Terms :
Laboratory Proficiency Testing*
Antibodies, Viral/*blood
COVID-19/*diagnosis
COVID-19 Serological Testing/*methods
COVID-19 Serological Testing/*standards
SARS-CoV-2/*immunology
COVID-19/blood ; COVID-19/immunology ; COVID-19/virology ; Humans ; Immunoglobulin G/blood ; Reproducibility of Results ; United States
Czasopismo naukowe
Tytuł :
Identification of SARS-CoV-2 in a Proficiency Testing Program.
Autorzy :
Edson DC; American Proficiency Institute, Traverse City, MI.
Casey DL; American Proficiency Institute, Traverse City, MI.
Harmer SE; American Proficiency Institute, Traverse City, MI.
Downes FP; Michigan State University College of Natural Science, East Lansing.
Pokaż więcej
Źródło :
American journal of clinical pathology [Am J Clin Pathol] 2020 Sep 08; Vol. 154 (4), pp. 475-478.
Typ publikacji :
Journal Article
MeSH Terms :
Laboratory Proficiency Testing*
Betacoronavirus/*isolation & purification
Clinical Laboratory Services/*standards
Clinical Laboratory Techniques/*standards
Coronavirus Infections/*diagnosis
Pneumonia, Viral/*diagnosis
Betacoronavirus/genetics ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques/methods ; Humans ; Pandemics ; RNA, Viral/analysis ; RNA, Viral/isolation & purification ; SARS-CoV-2 ; United States
Czasopismo naukowe
Tytuł :
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany.
Autorzy :
Selb R; Department of Infectious Diseases, Unit for Mycotic and Parasitic Agents and Mycobacteria, Robert Koch Institute, Seestrasse 10, 13353, Berlin, Germany. .; European Programme for Public Health Microbiology (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. .
Jansen K; Department of Infectious Disease Epidemiology, Unit for HIV/AIDS, STI and Blood-borne Infections, Robert Koch-Institute, Berlin, Germany.
Eckardt M; Department of Infectious Diseases, Postgraduate Training for Applied Epidemiology (PAE), Robert Koch-Institute, Berlin, Germany.
Tamminga T; Department of Infectious Disease Epidemiology, Unit for HIV/AIDS, STI and Blood-borne Infections, Robert Koch-Institute, Berlin, Germany.
Dudareva S; Department of Infectious Disease Epidemiology, Unit for HIV/AIDS, STI and Blood-borne Infections, Robert Koch-Institute, Berlin, Germany.
Gassowski M; Department of Infectious Diseases, Postgraduate Training for Applied Epidemiology (PAE), Robert Koch-Institute, Berlin, Germany.
Graeber I; Department of Dermatology and Venerology, German Reference Laboratory for Gonococci, Vivantes Hospital Berlin Neukölln, Berlin, Germany.
Guhl E; Department of Dermatology and Venerology, German Reference Laboratory for Gonococci, Vivantes Hospital Berlin Neukölln, Berlin, Germany.
Heuer D; Department of Infectious Diseases, Unit for Sexually Transmitted Bacterial Infections, Robert Koch-Institute, Berlin, Germany.
Buder S; Department of Dermatology and Venerology, German Reference Laboratory for Gonococci, Vivantes Hospital Berlin Neukölln, Berlin, Germany.; Department of Infectious Diseases, Unit for Sexually Transmitted Bacterial Infections, Robert Koch-Institute, Berlin, Germany.
Pokaż więcej
Corporate Authors :
GORENET EQA study group
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 Jul 16; Vol. 20 (1), pp. 514. Date of Electronic Publication: 2020 Jul 16.
Typ publikacji :
Journal Article
MeSH Terms :
Laboratory Proficiency Testing*/methods
Anti-Bacterial Agents/*therapeutic use
Drug Resistance, Bacterial/*drug effects
Gonorrhea/*drug therapy
Laboratories/*standards
Neisseria gonorrhoeae/*drug effects
Anti-Bacterial Agents/pharmacology ; Azithromycin/pharmacology ; Azithromycin/therapeutic use ; Cefixime/pharmacology ; Cefixime/therapeutic use ; Ceftriaxone/pharmacology ; Ceftriaxone/therapeutic use ; Ciprofloxacin/pharmacology ; Ciprofloxacin/therapeutic use ; Germany ; Gonorrhea/microbiology ; Humans ; Microbial Sensitivity Tests ; Penicillins/pharmacology ; Penicillins/therapeutic use ; Quality Control ; Reference Standards ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation.
Autorzy :
Keppens C; Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, University of Leuven, Leuven, Belgium.
Dequeker EM; Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, University of Leuven, Leuven, Belgium.
Pauwels P; Center for Oncologic Research (CORE), University of Antwerp, Antwerp, Belgium.; Department of Pathology, University Hospital Antwerp, Edegem, Belgium.
Ryska A; Department of Pathology, Charles University Medical Faculty and University Hospital, Hradec Kralove, Czech Republic.
't Hart N; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pathology, Isala Klinieken, Zwolle, The Netherlands.
von der Thüsen JH; Department of Pathology, University Medical Center Rotterdam, Erasmus MC, Rotterdam, The Netherlands. .
Pokaż więcej
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2021 May; Vol. 478 (5), pp. 827-839. Date of Electronic Publication: 2020 Dec 04.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Immunohistochemistry*
B7-H1 Antigen/*analysis
Biomarkers, Tumor/*analysis
Carcinoma, Non-Small-Cell Lung/*immunology
Lung Neoplasms/*immunology
Artifacts ; B7-H1 Antigen/antagonists & inhibitors ; Biomarkers, Tumor/antagonists & inhibitors ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/pathology ; Clinical Decision-Making ; Europe ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Laboratory Proficiency Testing ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Observer Variation ; Predictive Value of Tests ; Reproducibility of Results ; Tissue Array Analysis
Czasopismo naukowe
Tytuł :
[Study on Proficiency Testing of Determination Potassium in Serum].
Autorzy :
Yu T; National Institutes for Food and Drug Control, Beijing, 100050.
Ma L; National Institutes for Food and Drug Control, Beijing, 100050.
Zhang J; Medical Instrument Testing Institute of Henan, Zhengzhou, 450003.
Qu S; National Institutes for Food and Drug Control, Beijing, 100050.
Sun N; National Institutes for Food and Drug Control, Beijing, 100050.
Sun J; National Institutes for Food and Drug Control, Beijing, 100050.
Li L; National Institutes for Food and Drug Control, Beijing, 100050. E-mail:.
Xiang X; National Institutes for Food and Drug Control, Beijing, 100050. E-mail:.
Pokaż więcej
Źródło :
Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation [Zhongguo Yi Liao Qi Xie Za Zhi] 2021 Apr 08; Vol. 45 (2), pp. 219-223.
Typ publikacji :
Journal Article
MeSH Terms :
Drinking Water*/analysis
Potassium*
Laboratories ; Laboratory Proficiency Testing
Czasopismo naukowe
Tytuł :
Comprehensive competency assessment of malaria microscopists and laboratory diagnostic service capacity in districts stratified for malaria elimination in Ethiopia​.
Autorzy :
Nega D; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Abebe A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Abera A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Gidey B; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
G/Tsadik A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Tasew G; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Jun 25; Vol. 15 (6), pp. e0235151. Date of Electronic Publication: 2020 Jun 25 (Print Publication: 2020).
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Diagnostic Services*
Laboratory Proficiency Testing*
Malaria, Falciparum*/diagnosis
Malaria, Falciparum*/epidemiology
Malaria, Falciparum*/prevention & control
Microscopy*
Adult ; Cross-Sectional Studies ; Ethiopia/epidemiology ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Alanine Aminotransferase Results Differ by Analyzer Manufacturer in a National Integrated Health Setting, 2012-2017.
Autorzy :
Beste LA; From the General Medicine Service (Dr Beste) and Health Services Research and Development (Drs Beste, Lowy, and Taylor, and Ms Gylys-Colwell), VA Puget Sound Health Care System, Seattle, Washington; General Internal Medicine, University of Washington School of Medicine, Seattle (Dr Beste); Pathology Service, VA Iowa City, Iowa City (Dr Icardi); Pathology Department, University of Iowa Carver College of Medicine, Iowa City (Dr Icardi); Cooperative Studies Program Epidemiology Center, Durham VA Health Care System, Durham, North Carolina (Dr Hunt); Gastroenterology Service, Duke University Medical Center, Durham, North Carolina (Dr Hunt); Department of Health Services, University of Washington School of Public Health, Seattle (Dr Lowy); Medical Service, VA Long Beach Healthcare System, Long Beach, California (Dr Morgan); Gastroenterology Section, University of California, Irvine (Dr Morgan); Medical Service, VA Portland Health Care System, Portland, Oregon (Drs Chang and Maier); Gastroenterology Service (Dr Chang) and Infectious Diseases Service (Dr Maier), Oregon Health and Sciences University School of Medicine, Portland; the Department of Medicine (Gastroenterology and Hepatology), VA Palo Alto Health Care System, Palo Alto, California (Dr Cheung); and Medical Service (Gastroenterology and Hepatology), Stanford University, Palo Alto, California (Dr Cheung).
Icardi M; From the General Medicine Service (Dr Beste) and Health Services Research and Development (Drs Beste, Lowy, and Taylor, and Ms Gylys-Colwell), VA Puget Sound Health Care System, Seattle, Washington; General Internal Medicine, University of Washington School of Medicine, Seattle (Dr Beste); Pathology Service, VA Iowa City, Iowa City (Dr Icardi); Pathology Department, University of Iowa Carver College of Medicine, Iowa City (Dr Icardi); Cooperative Studies Program Epidemiology Center, Durham VA Health Care System, Durham, North Carolina (Dr Hunt); Gastroenterology Service, Duke University Medical Center, Durham, North Carolina (Dr Hunt); Department of Health Services, University of Washington School of Public Health, Seattle (Dr Lowy); Medical Service, VA Long Beach Healthcare System, Long Beach, California (Dr Morgan); Gastroenterology Section, University of California, Irvine (Dr Morgan); Medical Service, VA Portland Health Care System, Portland, Oregon (Drs Chang and Maier); Gastroenterology Service (Dr Chang) and Infectious Diseases Service (Dr Maier), Oregon Health and Sciences University School of Medicine, Portland; the Department of Medicine (Gastroenterology and Hepatology), VA Palo Alto Health Care System, Palo Alto, California (Dr Cheung); and Medical Service (Gastroenterology and Hepatology), Stanford University, Palo Alto, California (Dr Cheung).
Hunt CM; From the General Medicine Service (Dr Beste) and Health Services Research and Development (Drs Beste, Lowy, and Taylor, and Ms Gylys-Colwell), VA Puget Sound Health Care System, Seattle, Washington; General Internal Medicine, University of Washington School of Medicine, Seattle (Dr Beste); Pathology Service, VA Iowa City, Iowa City (Dr Icardi); Pathology Department, University of Iowa Carver College of Medicine, Iowa City (Dr Icardi); Cooperative Studies Program Epidemiology Center, Durham VA Health Care System, Durham, North Carolina (Dr Hunt); Gastroenterology Service, Duke University Medical Center, Durham, North Carolina (Dr Hunt); Department of Health Services, University of Washington School of Public Health, Seattle (Dr Lowy); Medical Service, VA Long Beach Healthcare System, Long Beach, California (Dr Morgan); Gastroenterology Section, University of California, Irvine (Dr Morgan); Medical Service, VA Portland Health Care System, Portland, Oregon (Drs Chang and Maier); Gastroenterology Service (Dr Chang) and Infectious Diseases Service (Dr Maier), Oregon Health and Sciences University School of Medicine, Portland; the Department of Medicine (Gastroenterology and Hepatology), VA Palo Alto Health Care System, Palo Alto, California (Dr Cheung); and Medical Service (Gastroenterology and Hepatology), Stanford University, Palo Alto, California (Dr Cheung).
Gylys-Colwell I; From the General Medicine Service (Dr Beste) and Health Services Research and Development (Drs Beste, Lowy, and Taylor, and Ms Gylys-Colwell), VA Puget Sound Health Care System, Seattle, Washington; General Internal Medicine, University of Washington School of Medicine, Seattle (Dr Beste); Pathology Service, VA Iowa City, Iowa City (Dr Icardi); Pathology Department, University of Iowa Carver College of Medicine, Iowa City (Dr Icardi); Cooperative Studies Program Epidemiology Center, Durham VA Health Care System, Durham, North Carolina (Dr Hunt); Gastroenterology Service, Duke University Medical Center, Durham, North Carolina (Dr Hunt); Department of Health Services, University of Washington School of Public Health, Seattle (Dr Lowy); Medical Service, VA Long Beach Healthcare System, Long Beach, California (Dr Morgan); Gastroenterology Section, University of California, Irvine (Dr Morgan); Medical Service, VA Portland Health Care System, Portland, Oregon (Drs Chang and Maier); Gastroenterology Service (Dr Chang) and Infectious Diseases Service (Dr Maier), Oregon Health and Sciences University School of Medicine, Portland; the Department of Medicine (Gastroenterology and Hepatology), VA Palo Alto Health Care System, Palo Alto, California (Dr Cheung); and Medical Service (Gastroenterology and Hepatology), Stanford University, Palo Alto, California (Dr Cheung).
Lowy E; From the General Medicine Service (Dr Beste) and Health Services Research and Development (Drs Beste, Lowy, and Taylor, and Ms Gylys-Colwell), VA Puget Sound Health Care System, Seattle, Washington; General Internal Medicine, University of Washington School of Medicine, Seattle (Dr Beste); Pathology Service, VA Iowa City, Iowa City (Dr Icardi); Pathology Department, University of Iowa Carver College of Medicine, Iowa City (Dr Icardi); Cooperative Studies Program Epidemiology Center, Durham VA Health Care System, Durham, North Carolina (Dr Hunt); Gastroenterology Service, Duke University Medical Center, Durham, North Carolina (Dr Hunt); Department of Health Services, University of Washington School of Public Health, Seattle (Dr Lowy); Medical Service, VA Long Beach Healthcare System, Long Beach, California (Dr Morgan); Gastroenterology Section, University of California, Irvine (Dr Morgan); Medical Service, VA Portland Health Care System, Portland, Oregon (Drs Chang and Maier); Gastroenterology Service (Dr Chang) and Infectious Diseases Service (Dr Maier), Oregon Health and Sciences University School of Medicine, Portland; the Department of Medicine (Gastroenterology and Hepatology), VA Palo Alto Health Care System, Palo Alto, California (Dr Cheung); and Medical Service (Gastroenterology and Hepatology), Stanford University, Palo Alto, California (Dr Cheung).
Taylor L; From the General Medicine Service (Dr Beste) and Health Services Research and Development (Drs Beste, Lowy, and Taylor, and Ms Gylys-Colwell), VA Puget Sound Health Care System, Seattle, Washington; General Internal Medicine, University of Washington School of Medicine, Seattle (Dr Beste); Pathology Service, VA Iowa City, Iowa City (Dr Icardi); Pathology Department, University of Iowa Carver College of Medicine, Iowa City (Dr Icardi); Cooperative Studies Program Epidemiology Center, Durham VA Health Care System, Durham, North Carolina (Dr Hunt); Gastroenterology Service, Duke University Medical Center, Durham, North Carolina (Dr Hunt); Department of Health Services, University of Washington School of Public Health, Seattle (Dr Lowy); Medical Service, VA Long Beach Healthcare System, Long Beach, California (Dr Morgan); Gastroenterology Section, University of California, Irvine (Dr Morgan); Medical Service, VA Portland Health Care System, Portland, Oregon (Drs Chang and Maier); Gastroenterology Service (Dr Chang) and Infectious Diseases Service (Dr Maier), Oregon Health and Sciences University School of Medicine, Portland; the Department of Medicine (Gastroenterology and Hepatology), VA Palo Alto Health Care System, Palo Alto, California (Dr Cheung); and Medical Service (Gastroenterology and Hepatology), Stanford University, Palo Alto, California (Dr Cheung).
Morgan TR; From the General Medicine Service (Dr Beste) and Health Services Research and Development (Drs Beste, Lowy, and Taylor, and Ms Gylys-Colwell), VA Puget Sound Health Care System, Seattle, Washington; General Internal Medicine, University of Washington School of Medicine, Seattle (Dr Beste); Pathology Service, VA Iowa City, Iowa City (Dr Icardi); Pathology Department, University of Iowa Carver College of Medicine, Iowa City (Dr Icardi); Cooperative Studies Program Epidemiology Center, Durham VA Health Care System, Durham, North Carolina (Dr Hunt); Gastroenterology Service, Duke University Medical Center, Durham, North Carolina (Dr Hunt); Department of Health Services, University of Washington School of Public Health, Seattle (Dr Lowy); Medical Service, VA Long Beach Healthcare System, Long Beach, California (Dr Morgan); Gastroenterology Section, University of California, Irvine (Dr Morgan); Medical Service, VA Portland Health Care System, Portland, Oregon (Drs Chang and Maier); Gastroenterology Service (Dr Chang) and Infectious Diseases Service (Dr Maier), Oregon Health and Sciences University School of Medicine, Portland; the Department of Medicine (Gastroenterology and Hepatology), VA Palo Alto Health Care System, Palo Alto, California (Dr Cheung); and Medical Service (Gastroenterology and Hepatology), Stanford University, Palo Alto, California (Dr Cheung).
Chang MF; From the General Medicine Service (Dr Beste) and Health Services Research and Development (Drs Beste, Lowy, and Taylor, and Ms Gylys-Colwell), VA Puget Sound Health Care System, Seattle, Washington; General Internal Medicine, University of Washington School of Medicine, Seattle (Dr Beste); Pathology Service, VA Iowa City, Iowa City (Dr Icardi); Pathology Department, University of Iowa Carver College of Medicine, Iowa City (Dr Icardi); Cooperative Studies Program Epidemiology Center, Durham VA Health Care System, Durham, North Carolina (Dr Hunt); Gastroenterology Service, Duke University Medical Center, Durham, North Carolina (Dr Hunt); Department of Health Services, University of Washington School of Public Health, Seattle (Dr Lowy); Medical Service, VA Long Beach Healthcare System, Long Beach, California (Dr Morgan); Gastroenterology Section, University of California, Irvine (Dr Morgan); Medical Service, VA Portland Health Care System, Portland, Oregon (Drs Chang and Maier); Gastroenterology Service (Dr Chang) and Infectious Diseases Service (Dr Maier), Oregon Health and Sciences University School of Medicine, Portland; the Department of Medicine (Gastroenterology and Hepatology), VA Palo Alto Health Care System, Palo Alto, California (Dr Cheung); and Medical Service (Gastroenterology and Hepatology), Stanford University, Palo Alto, California (Dr Cheung).
Maier MM; From the General Medicine Service (Dr Beste) and Health Services Research and Development (Drs Beste, Lowy, and Taylor, and Ms Gylys-Colwell), VA Puget Sound Health Care System, Seattle, Washington; General Internal Medicine, University of Washington School of Medicine, Seattle (Dr Beste); Pathology Service, VA Iowa City, Iowa City (Dr Icardi); Pathology Department, University of Iowa Carver College of Medicine, Iowa City (Dr Icardi); Cooperative Studies Program Epidemiology Center, Durham VA Health Care System, Durham, North Carolina (Dr Hunt); Gastroenterology Service, Duke University Medical Center, Durham, North Carolina (Dr Hunt); Department of Health Services, University of Washington School of Public Health, Seattle (Dr Lowy); Medical Service, VA Long Beach Healthcare System, Long Beach, California (Dr Morgan); Gastroenterology Section, University of California, Irvine (Dr Morgan); Medical Service, VA Portland Health Care System, Portland, Oregon (Drs Chang and Maier); Gastroenterology Service (Dr Chang) and Infectious Diseases Service (Dr Maier), Oregon Health and Sciences University School of Medicine, Portland; the Department of Medicine (Gastroenterology and Hepatology), VA Palo Alto Health Care System, Palo Alto, California (Dr Cheung); and Medical Service (Gastroenterology and Hepatology), Stanford University, Palo Alto, California (Dr Cheung).
Cheung R; From the General Medicine Service (Dr Beste) and Health Services Research and Development (Drs Beste, Lowy, and Taylor, and Ms Gylys-Colwell), VA Puget Sound Health Care System, Seattle, Washington; General Internal Medicine, University of Washington School of Medicine, Seattle (Dr Beste); Pathology Service, VA Iowa City, Iowa City (Dr Icardi); Pathology Department, University of Iowa Carver College of Medicine, Iowa City (Dr Icardi); Cooperative Studies Program Epidemiology Center, Durham VA Health Care System, Durham, North Carolina (Dr Hunt); Gastroenterology Service, Duke University Medical Center, Durham, North Carolina (Dr Hunt); Department of Health Services, University of Washington School of Public Health, Seattle (Dr Lowy); Medical Service, VA Long Beach Healthcare System, Long Beach, California (Dr Morgan); Gastroenterology Section, University of California, Irvine (Dr Morgan); Medical Service, VA Portland Health Care System, Portland, Oregon (Drs Chang and Maier); Gastroenterology Service (Dr Chang) and Infectious Diseases Service (Dr Maier), Oregon Health and Sciences University School of Medicine, Portland; the Department of Medicine (Gastroenterology and Hepatology), VA Palo Alto Health Care System, Palo Alto, California (Dr Cheung); and Medical Service (Gastroenterology and Hepatology), Stanford University, Palo Alto, California (Dr Cheung).
Pokaż więcej
Źródło :
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2020 Jun; Vol. 144 (6), pp. 748-754. Date of Electronic Publication: 2019 Nov 07.
Typ publikacji :
Journal Article
MeSH Terms :
Laboratory Proficiency Testing*
Alanine Transaminase/*blood
Blood Chemical Analysis/*instrumentation
Humans ; Laboratories/standards
Czasopismo naukowe
Tytuł :
Retrospection of Anti-Blood Group Antibody Proficiency Testing Data Using the Geometric Mean and Standard Deviation.
Autorzy :
Yang JJ; Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.
Chung Y; Department of Laboratory Medicine, Kangdong Sacred Heart Hospital, Seoul, Korea.
Kim H; Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea.
Ko DH; Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.
Hwang SH; Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.
Oh HB; Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.
Pokaż więcej
Źródło :
American journal of clinical pathology [Am J Clin Pathol] 2020 Mar 09; Vol. 153 (4), pp. 530-536.
Typ publikacji :
Journal Article
MeSH Terms :
Laboratory Proficiency Testing*
Blood Group Antigens/*immunology
Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Interpretation and Utility of Drug of Abuse Screening Immunoassays: Insights From Laboratory Drug Testing Proficiency Surveys.
Autorzy :
Krasowski MD; From the Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City (Dr Krasowski); the Department of Pathology, University of Utah School of Medicine, ARUP Laboratories, Salt Lake City (Dr McMillin); the Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Dr Melanson); the Proficiency Testing Division, College of American Pathologists, Northfield, Illinois (Ms Dizon); the Department of Pathology and Laboratory Medicine, Tufts Medical Center, and Department of Anatomic and Clinical Pathology, Tufts University School of Medicine, Boston, Massachusetts (Dr Magnani); and the Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale (Dr Snozek).
McMillin GA; From the Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City (Dr Krasowski); the Department of Pathology, University of Utah School of Medicine, ARUP Laboratories, Salt Lake City (Dr McMillin); the Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Dr Melanson); the Proficiency Testing Division, College of American Pathologists, Northfield, Illinois (Ms Dizon); the Department of Pathology and Laboratory Medicine, Tufts Medical Center, and Department of Anatomic and Clinical Pathology, Tufts University School of Medicine, Boston, Massachusetts (Dr Magnani); and the Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale (Dr Snozek).
Melanson SEF; From the Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City (Dr Krasowski); the Department of Pathology, University of Utah School of Medicine, ARUP Laboratories, Salt Lake City (Dr McMillin); the Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Dr Melanson); the Proficiency Testing Division, College of American Pathologists, Northfield, Illinois (Ms Dizon); the Department of Pathology and Laboratory Medicine, Tufts Medical Center, and Department of Anatomic and Clinical Pathology, Tufts University School of Medicine, Boston, Massachusetts (Dr Magnani); and the Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale (Dr Snozek).
Dizon A; From the Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City (Dr Krasowski); the Department of Pathology, University of Utah School of Medicine, ARUP Laboratories, Salt Lake City (Dr McMillin); the Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Dr Melanson); the Proficiency Testing Division, College of American Pathologists, Northfield, Illinois (Ms Dizon); the Department of Pathology and Laboratory Medicine, Tufts Medical Center, and Department of Anatomic and Clinical Pathology, Tufts University School of Medicine, Boston, Massachusetts (Dr Magnani); and the Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale (Dr Snozek).
Magnani B; From the Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City (Dr Krasowski); the Department of Pathology, University of Utah School of Medicine, ARUP Laboratories, Salt Lake City (Dr McMillin); the Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Dr Melanson); the Proficiency Testing Division, College of American Pathologists, Northfield, Illinois (Ms Dizon); the Department of Pathology and Laboratory Medicine, Tufts Medical Center, and Department of Anatomic and Clinical Pathology, Tufts University School of Medicine, Boston, Massachusetts (Dr Magnani); and the Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale (Dr Snozek).
Snozek CLH; From the Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City (Dr Krasowski); the Department of Pathology, University of Utah School of Medicine, ARUP Laboratories, Salt Lake City (Dr McMillin); the Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Dr Melanson); the Proficiency Testing Division, College of American Pathologists, Northfield, Illinois (Ms Dizon); the Department of Pathology and Laboratory Medicine, Tufts Medical Center, and Department of Anatomic and Clinical Pathology, Tufts University School of Medicine, Boston, Massachusetts (Dr Magnani); and the Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale (Dr Snozek).
Pokaż więcej
Źródło :
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2020 Feb; Vol. 144 (2), pp. 177-184. Date of Electronic Publication: 2019 Jul 17.
Typ publikacji :
Journal Article
MeSH Terms :
Laboratory Proficiency Testing*
Substance Abuse Detection*
Immunoassay/*methods
Analgesics, Opioid/analysis ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Log transformation of proficiency testing data on the content of genetically modified organisms in food and feed samples: is it justified?
Autorzy :
Broothaerts W; European Commission, Joint Research Centre (JRC), Geel, Belgium. .
Cordeiro F; European Commission, Joint Research Centre (JRC), Geel, Belgium.
Corbisier P; European Commission, Joint Research Centre (JRC), Geel, Belgium.
Robouch P; European Commission, Joint Research Centre (JRC), Geel, Belgium.
Emons H; European Commission, Joint Research Centre (JRC), Geel, Belgium.
Pokaż więcej
Źródło :
Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2020 Feb; Vol. 412 (5), pp. 1129-1136. Date of Electronic Publication: 2019 Dec 21.
Typ publikacji :
Journal Article
MeSH Terms :
Food Microbiology*
Laboratory Proficiency Testing*
Organisms, Genetically Modified*
Animal Feed/*microbiology
Datasets as Topic ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
[Proficiency Testing Schemes for Food Nutrition Analysis in Japan (2017-2018)].
Autorzy :
Takebayashi J; National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition.
Takasaka N; Hatano Research Institute, Food and Drug Safety Center.
Suzuki I; National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition.
Nakasaka T; Hatano Research Institute, Food and Drug Safety Center.
Hirabayashi N; Hatano Research Institute, Food and Drug Safety Center.
Ishimi Y; National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition.; NODAI Research Institute, Tokyo University of Agriculture.
Umegaki K; National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition.; Department of Food Safety and Management, Showa Women's University.
Chiba T; National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition.
Watanabe T; Hatano Research Institute, Food and Drug Safety Center.
Pokaż więcej
Źródło :
Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan [Shokuhin Eiseigaku Zasshi] 2020; Vol. 61 (2), pp. 63-71.
Typ publikacji :
Journal Article
MeSH Terms :
Food Labeling*
Laboratory Proficiency Testing*
Food Analysis/*standards
Japan ; Laboratories
Czasopismo naukowe
Tytuł :
Evaluation of INSTAND e.V.'s external proficiency testing program for tetanus and diphtheria antitoxin detection: Lessons for assessing levels of immunoprotection.
Autorzy :
Wojtalewicz N; INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories, Ubierstr. 20, 40223 Duesseldorf, Germany. Electronic address: .
Vierbaum L; INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories, Ubierstr. 20, 40223 Duesseldorf, Germany.
Schellenberg I; INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories, Ubierstr. 20, 40223 Duesseldorf, Germany; Institute of Bioanalytical Sciences (IBAS), Center of Life Sciences, Anhalt University of Applied Sciences, Strenzfelder Allee 28, 06406 Bernburg, Germany.
Hunfeld KP; INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories, Ubierstr. 20, 40223 Duesseldorf, Germany; Institute for Laboratory Medicine, Microbiology & Infection Control, Northwest Medical Centre, Medical Faculty Goethe University, Steinbacher Hohl 2-26, 60488 Frankfurt/Main, Germany.
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Mar; Vol. 104, pp. 85-91. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Diphtheria Antitoxin/*blood
Tetanus Antitoxin/*blood
Diphtheria/immunology ; Humans ; Immunologic Techniques/standards ; Laboratory Proficiency Testing ; Tetanus/immunology
Czasopismo naukowe
Tytuł :
Participation in the College of American Pathologists Laboratory Accreditation Program Decreases Variability in B-Lymphoblastic Leukemia and Plasma Cell Myeloma Flow Cytometric Minimal Residual Disease Testing: A Follow-up Survey.
Autorzy :
Hupp MM; From the Division of Hematopathology, Department of Laboratory Medicine and Pathology, University of Minnesota Medical Center, Minneapolis (Hupp, Linden).
Bashleben C; College of American Pathologists, Northfield, Illinois (Bashleben, Long).
Cardinali JL; Special Hematology, Hartford Hospital, Hartford, Connecticut (Cardinali).
Dorfman DM; The Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dorfman).
Karlon W; The Departments of Pathology and Laboratory Medicine, University of California, San Francisco (Karlon).
Keeney M; London Health Sciences Centre, Lawson Health Research Institute, London, Ontario, Canada (Keeney).
Leith C; The Department of Pathology and Laboratory Medicine, University of Wisconsin Hospital and Clinics, Madison (Leith).
Long T; College of American Pathologists, Northfield, Illinois (Bashleben, Long).
Murphy CE; Summit Pathology, Fort Collins, Colorado (Murphy).
Pillai V; the Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania (Pillai).
Rosado FN; The Department of Pathology and Laboratory Services, University of Texas Southwestern Medical Center, Dallas (Rosado).
Seegmiller AC; The Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Seegmiller).
Linden MA; From the Division of Hematopathology, Department of Laboratory Medicine and Pathology, University of Minnesota Medical Center, Minneapolis (Hupp, Linden).
Pokaż więcej
Źródło :
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2021 Mar 01; Vol. 145 (3), pp. 336-342.
Typ publikacji :
Journal Article
MeSH Terms :
Laboratory Proficiency Testing/*standards
Multiple Myeloma/*diagnosis
Neoplasm, Residual/*diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*diagnosis
Accreditation ; American Medical Association ; Flow Cytometry ; Follow-Up Studies ; Humans ; Immunophenotyping ; Multiple Myeloma/pathology ; Neoplasm, Residual/pathology ; Pathologists ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Surveys and Questionnaires ; United States
Czasopismo naukowe
Tytuł :
Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee.
Autorzy :
Larson DP; The Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Larson, Van Dyke, Kearney, Ketterling, Peterson, Yuhas).
Akkari YM; The Department of Molecular Diagnostics, Legacy Laboratory Services, Legacy Health, Portland, Oregon (Akkari).
Van Dyke DL; The Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Larson, Van Dyke, Kearney, Ketterling, Peterson, Yuhas).
Raca G; The Department of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, Los Angeles, California (Raca).
Gardner JA; The Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington (Gardner).
Rehder CW; The Department of Pathology, Duke University School of Medicine, Durham, North Carolina (Rehder).
Kaiser-Rogers KA; The Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill (Kaiser-Rogers).
Eagle P; College of American Pathologists, Northfield, Illinois (Eagle).
Yuhas JA; The Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Larson, Van Dyke, Kearney, Ketterling, Peterson, Yuhas).
Gu J; School of Health Professionals (Gu) and the Department of Hematopathology (Tang), The University of Texas MD Anderson Cancer Center, Houston, Texas.
Toydemir RM; The Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania (Conlin).
Kearney H; The Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Larson, Van Dyke, Kearney, Ketterling, Peterson, Yuhas).
Conlin LK; The Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis (Dolan).
Tang G; The Department of Pathology, University of Utah, Salt Lake City (Toydemir).
Dolan MM
Ketterling RP; The Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Larson, Van Dyke, Kearney, Ketterling, Peterson, Yuhas).
Peterson JF; The Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Larson, Van Dyke, Kearney, Ketterling, Peterson, Yuhas).
Pokaż więcej
Źródło :
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2021 Feb 01; Vol. 145 (2), pp. 176-190.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Chromosome Aberrations*
Hematologic Neoplasms/*diagnosis
Laboratory Proficiency Testing/*statistics & numerical data
American Medical Association ; Cytogenetic Analysis ; Genetics, Medical ; Genomics ; Hematologic Neoplasms/genetics ; Humans ; Karyotype ; Pathologists ; Professional Staff Committees ; United States
Czasopismo naukowe
Tytuł :
Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial.
Autorzy :
De Winne K; Laboratory of Pathological Anatomy, Antwerp University Hospital (UZA), 2650, Edegem, Belgium. .
Sorber L; Center for Oncological Research Antwerp (CORE), University of Antwerp (UAntwerp), 2610, Wilrijk, Belgium.
Lambin S; Laboratory of Pathological Anatomy, Antwerp University Hospital (UZA), 2650, Edegem, Belgium.
Siozopoulou V; Laboratory of Pathological Anatomy, Antwerp University Hospital (UZA), 2650, Edegem, Belgium.; Center for Oncological Research Antwerp (CORE), University of Antwerp (UAntwerp), 2610, Wilrijk, Belgium.
Beniuga G; Institute of Pathology and Genetics, 6280, Loverval, Belgium.
Dedeurwaerdere F; Department of Pathology, AZ Delta, 8800, Roeselare, Belgium.
D'Haene N; Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Route de Lennik 808, 1070, Brussels, Belgium.
Habran L; Anatomopathology Department, Centre Hospitalier Universitaire (CHU) de Liège, 4000, Liège, Belgium.
Libbrecht L; Department of Pathology, University Hospital Saint-Luc, 1200, Sint-Lambrechts-Woluwe, Belgium.
Van Huysse J; Department of Pathology, AZ Sint Jan, 8000, Brugge, Belgium.
Weynand B; Department of Pathology, University Hospital Leuven, 3000, Leuven, Belgium.
Wouters K; Department of Pathology, Jessa Hospital, 3500, Hasselt, Belgium.
Pauwels P; Laboratory of Pathological Anatomy, Antwerp University Hospital (UZA), 2650, Edegem, Belgium.; Center for Oncological Research Antwerp (CORE), University of Antwerp (UAntwerp), 2610, Wilrijk, Belgium.; Biobank UZA/UAntwerpen, Antwerp University Hospital (UZA), Edegem, Belgium.
Zwaenepoel K; Laboratory of Pathological Anatomy, Antwerp University Hospital (UZA), 2650, Edegem, Belgium.; Center for Oncological Research Antwerp (CORE), University of Antwerp (UAntwerp), 2610, Wilrijk, Belgium.
Pokaż więcej
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2021 Feb; Vol. 478 (2), pp. 283-291. Date of Electronic Publication: 2020 Sep 11.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms :
Early Detection of Cancer*
Gene Fusion*
Immunohistochemistry*
Biomarkers, Tumor/*genetics
Neoplasms/*genetics
Receptors, Nerve Growth Factor/*genetics
Belgium ; Genetic Predisposition to Disease ; Humans ; Laboratory Proficiency Testing ; Neoplasms/pathology ; Observer Variation ; Phenotype ; Predictive Value of Tests ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Proficiency test for rabies serology: A design complying with international standards for a reliable assessment of participating laboratories.
Autorzy :
Wasniewski M; ANSES, Nancy Laboratory for Rabies and Wildlife, European Union Reference Laboratory for Rabies Serology, European Union Reference Laboratory for Rabies, WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, Malzeville, France.
Laurentie M; ANSES-Platform of Statistical Analysis for proficiency testing and validation of analysis method (PAS), Fougères, France.
Rizzo F; ANSES, Nancy Laboratory for Rabies and Wildlife, European Union Reference Laboratory for Rabies Serology, European Union Reference Laboratory for Rabies, WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, Malzeville, France.
Servat A; ANSES, Nancy Laboratory for Rabies and Wildlife, European Union Reference Laboratory for Rabies Serology, European Union Reference Laboratory for Rabies, WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, Malzeville, France.
Aubert M; ANSES (retired) 1088 chemin des Maures, Callian, France.
Cliquet F; ANSES, Nancy Laboratory for Rabies and Wildlife, European Union Reference Laboratory for Rabies Serology, European Union Reference Laboratory for Rabies, WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, Malzeville, France.
Pokaż więcej
Źródło :
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2019 Dec 11; Vol. 13 (12), pp. e0007824. Date of Electronic Publication: 2019 Dec 11 (Print Publication: 2019).
Typ publikacji :
Journal Article
MeSH Terms :
Laboratory Proficiency Testing*
Antibodies, Viral/*blood
Dog Diseases/*diagnosis
Rabies/*veterinary
Rabies virus/*immunology
Serologic Tests/*methods
Animals ; Dogs ; European Union ; Neutralization Tests/methods ; Rabies/diagnosis
Czasopismo naukowe
Tytuł :
Inter-laboratory proficiency testing scheme for tumour next-generation sequencing in Ontario: a pilot study.
Autorzy :
Spence T; Toronto, ON: Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network (Spence, Stockley); Bioinformatics and HPC Core, Princess Margaret Cancer Centre, University Health Network (Stickle); Cancer Genomics Program, Princess Margaret Cancer Centre, University Health Network (Yu, Chow, Siu); Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network (Siu, Bedard); Department of Medicine, University of Toronto (Siu, Bedard); Department of Clinical Laboratory Genetics, University Health Network (Stockley); Department of Laboratory Medicine and Pathobiology, University of Toronto (Stockley).
Stickle N; Toronto, ON: Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network (Spence, Stockley); Bioinformatics and HPC Core, Princess Margaret Cancer Centre, University Health Network (Stickle); Cancer Genomics Program, Princess Margaret Cancer Centre, University Health Network (Yu, Chow, Siu); Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network (Siu, Bedard); Department of Medicine, University of Toronto (Siu, Bedard); Department of Clinical Laboratory Genetics, University Health Network (Stockley); Department of Laboratory Medicine and Pathobiology, University of Toronto (Stockley).
Yu C; Toronto, ON: Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network (Spence, Stockley); Bioinformatics and HPC Core, Princess Margaret Cancer Centre, University Health Network (Stickle); Cancer Genomics Program, Princess Margaret Cancer Centre, University Health Network (Yu, Chow, Siu); Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network (Siu, Bedard); Department of Medicine, University of Toronto (Siu, Bedard); Department of Clinical Laboratory Genetics, University Health Network (Stockley); Department of Laboratory Medicine and Pathobiology, University of Toronto (Stockley).
Chow H; Toronto, ON: Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network (Spence, Stockley); Bioinformatics and HPC Core, Princess Margaret Cancer Centre, University Health Network (Stickle); Cancer Genomics Program, Princess Margaret Cancer Centre, University Health Network (Yu, Chow, Siu); Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network (Siu, Bedard); Department of Medicine, University of Toronto (Siu, Bedard); Department of Clinical Laboratory Genetics, University Health Network (Stockley); Department of Laboratory Medicine and Pathobiology, University of Toronto (Stockley).
Feilotter H; Kingston, ON: Molecular Diagnostics, Kingston Health Sciences Centre (Feilotter); Department of Pathology and Molecular Medicine, Queen's University (Feilotter).
Lo B; Ottawa, ON: Molecular Oncology Diagnostics Laboratory, The Ottawa Hospital (Lo); Department of Pathology and Laboratory Medicine, University of Ottawa (Lo).
McCready E; Hamilton, ON: Hamilton Health Sciences and St. Joseph's Healthcare (McCready); Department of Pathology and Molecular Medicine, McMaster University (McCready).
Sadikovic B; London, ON: Pathology and Laboratory Medicine Program, London Health Sciences Centre (Sadikovic); Department of Pathology and Laboratory Medicine, Western University (Sadikovic).
Siu LL; Toronto, ON: Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network (Spence, Stockley); Bioinformatics and HPC Core, Princess Margaret Cancer Centre, University Health Network (Stickle); Cancer Genomics Program, Princess Margaret Cancer Centre, University Health Network (Yu, Chow, Siu); Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network (Siu, Bedard); Department of Medicine, University of Toronto (Siu, Bedard); Department of Clinical Laboratory Genetics, University Health Network (Stockley); Department of Laboratory Medicine and Pathobiology, University of Toronto (Stockley).
Bedard PL; Toronto, ON: Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network (Spence, Stockley); Bioinformatics and HPC Core, Princess Margaret Cancer Centre, University Health Network (Stickle); Cancer Genomics Program, Princess Margaret Cancer Centre, University Health Network (Yu, Chow, Siu); Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network (Siu, Bedard); Department of Medicine, University of Toronto (Siu, Bedard); Department of Clinical Laboratory Genetics, University Health Network (Stockley); Department of Laboratory Medicine and Pathobiology, University of Toronto (Stockley).
Stockley TL; Toronto, ON: Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network (Spence, Stockley); Bioinformatics and HPC Core, Princess Margaret Cancer Centre, University Health Network (Stickle); Cancer Genomics Program, Princess Margaret Cancer Centre, University Health Network (Yu, Chow, Siu); Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network (Siu, Bedard); Department of Medicine, University of Toronto (Siu, Bedard); Department of Clinical Laboratory Genetics, University Health Network (Stockley); Department of Laboratory Medicine and Pathobiology, University of Toronto (Stockley).
Pokaż więcej
Źródło :
Current oncology (Toronto, Ont.) [Curr Oncol] 2019 Dec; Vol. 26 (6), pp. e717-e732. Date of Electronic Publication: 2019 Dec 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
High-Throughput Nucleotide Sequencing*
Laboratory Proficiency Testing*
Neoplasms/*genetics
Humans ; Ontario ; Pilot Projects ; Reproducibility of Results ; Research Design
Czasopismo naukowe
Tytuł :
Heparin-induced thrombocytopenia: An international assessment of the quality of laboratory testing.
Autorzy :
Liederman Z; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Van Cott EM; Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
Smock K; Department of Pathology, University of Utah, Salt Lake City, UT, USA.; ARUP Laboratories, Hemostasis/Thrombosis Laboratory, Salt Lake City, UT, USA.
Meijer P; ECAT Foundation, External Quality Control for Assays and Tests, Voorschoten, the Netherlands.
Selby R; Department of Laboratory Medicine and Medicine, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2019 Dec; Vol. 17 (12), pp. 2123-2130. Date of Electronic Publication: 2019 Sep 25.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Laboratory Proficiency Testing*
Antibodies/*blood
Anticoagulants/*adverse effects
Enzyme-Linked Immunosorbent Assay/*standards
Heparin/*adverse effects
Platelet Factor 4/*immunology
Radioimmunoassay/*standards
Serologic Tests/*standards
Thrombocytopenia/*diagnosis
Anticoagulants/immunology ; Australia ; Biomarkers/blood ; Europe ; Heparin/immunology ; Humans ; Israel ; North America ; Observer Variation ; Predictive Value of Tests ; Reproducibility of Results ; Thrombocytopenia/blood ; Thrombocytopenia/chemically induced ; Thrombocytopenia/immunology
Czasopismo naukowe
Tytuł :
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.
Autorzy :
Efthymiou M; Haemostasis Research Unit, Department of Haematology, University College London, London, UK.
Mackie IJ; Haemostasis Research Unit, Department of Haematology, University College London, London, UK.
Lane PJ; Haemostasis Research Unit, Department of Haematology, University College London, London, UK.
Andrade D; University of Sao Paulo, Sao Paulo, Brazil.
Willis R; Antiphospholipid Standardization Laboratory, University of Texas Medical Branch, Galveston, TX, USA.
Erkan D; Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, USA.
Sciascia S; Center of Research of Immunopathology and Rare Diseases, University of Turin, Turin, Italy.
Krillis S; Department of Infectious Diseases, Immunology and Sexual Health, St George Hospital, Sydney, NSW, Australia.
Bison E; University Hospital Padova, Padova, Italy.
Borges Galhardo Vendramini M; University of Sao Paulo, Sao Paulo, Brazil.
Romay-Penabad Z; Antiphospholipid Standardization Laboratory, University of Texas Medical Branch, Galveston, TX, USA.
Qi M; Department of Infectious Diseases, Immunology and Sexual Health, St George Hospital, Sydney, NSW, Australia.
Tektonidou M; National and Kapodistrian University of Athens, Athens, Greece.
Ugarte A; Internal Medicine, Hospital Universitario Cruces, Barakaldo, País Vasco, Spain.
Chighizola C; University of Milan, Milan, Italy.
Belmont HM; School of Medicine, New York University, New York, NY, USA.
Aguirre MA; Maimonides Institute for Biomedical Research of Cordoba, Cordoba, Spain.
Ji L; Rheumatology and Immunology Department, Peking University First Hospital, Beijing, China.
Branch DW; University of Utah and Intermountain Healthcare, Salt Lake City, UT, USA.
de Jesus G; Rio de Janeiro State University, Rio de Janeiro, Brazil.
Fortin PR; CHU de Quebec - Université Laval, Quebec, QC, Canada.
Andreoli L; Rheumatology and Clinical Immunology, Spedali Civili, Brescia, Italy.; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Petri M; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Cervera R; Department of Autoimmune Diseases, Hospital Clínic Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
Rodriguez E; Hospital Universitario 12 de Octubre, Madrid, Spain.
Knight JS; Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA.
Atsumi T; Hokkaido University Hospital, Sapporo, Japan.
Vega J; University Hospital Padova, Padova, Italy.
Sevim E; University Hospital Padova, Padova, Italy.
Bertolaccini ML; Academic Department of Vascular Surgery, School of Cardiovascular Medicine & Sciences, King's College London, London, UK.
Pengo V; Department of Infectious Diseases, Immunology and Sexual Health, St George Hospital, Sydney, NSW, Australia.
Cohen H; Haemostasis Research Unit, Department of Haematology, University College London, London, UK.; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Pokaż więcej
Corporate Authors :
APS ACTION
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2019 Dec; Vol. 17 (12), pp. 2069-2080. Date of Electronic Publication: 2019 Sep 08.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Laboratory Proficiency Testing*
Antiphospholipid Syndrome/*diagnosis
Lupus Coagulation Inhibitor/*blood
Serologic Tests/*standards
Anticoagulants/blood ; Antiphospholipid Syndrome/blood ; Biomarkers/blood ; Clinical Trials as Topic ; Databases, Factual ; Humans ; Observer Variation ; Predictive Value of Tests ; Prospective Studies ; Prothrombin Time/standards ; Registries ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Accuracy-Based Vitamin D Survey: Six Years of Quality Improvement Guided by Proficiency Testing.
Autorzy :
Erdman P; From the Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Erdman); Regional Reference Labs, Southern California Permanente Medical Group, North Hollywood (Dr Palmer-Toy); the Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts (Dr Horowitz); and the Department of Laboratory Medicine, University of Washington, Seattle (Dr Hoofnagle).
Palmer-Toy DE; From the Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Erdman); Regional Reference Labs, Southern California Permanente Medical Group, North Hollywood (Dr Palmer-Toy); the Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts (Dr Horowitz); and the Department of Laboratory Medicine, University of Washington, Seattle (Dr Hoofnagle).
Horowitz G; From the Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Erdman); Regional Reference Labs, Southern California Permanente Medical Group, North Hollywood (Dr Palmer-Toy); the Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts (Dr Horowitz); and the Department of Laboratory Medicine, University of Washington, Seattle (Dr Hoofnagle).
Hoofnagle A; From the Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Erdman); Regional Reference Labs, Southern California Permanente Medical Group, North Hollywood (Dr Palmer-Toy); the Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts (Dr Horowitz); and the Department of Laboratory Medicine, University of Washington, Seattle (Dr Hoofnagle).
Pokaż więcej
Źródło :
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2019 Dec; Vol. 143 (12), pp. 1531-1538. Date of Electronic Publication: 2019 May 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Laboratory Proficiency Testing*
Quality Improvement*
Laboratories/*standards
Vitamin D/*blood
Humans ; Surveys and Questionnaires
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies